118491,0,Admission,O
118491,0,Date,O
118491,0,:,O
118491,0,[,O
118491,0,*,O
118491,0,*,O
118491,0,2106-5-27,O
118491,0,*,O
118491,0,*,O
118491,0,],O
118491,0,Discharge,O
118491,0,Date,O
118491,0,:,O
118491,0,[,O
118491,0,*,O
118491,0,*,O
118491,0,2106-6-20,O
118491,0,*,O
118491,0,*,O
118491,0,],O
118491,0,Date,O
118491,0,of,O
118491,0,Birth,O
118491,0,:,O
118491,0,[,O
118491,0,*,O
118491,0,*,O
118491,0,2060-12-28,O
118491,0,*,O
118491,0,*,O
118491,0,],O
118491,0,Sex,O
118491,0,:,O
118491,0,F,O
118491,0,Service,O
118491,0,:,O
118491,0,MEDICINE,O
118491,0,Allergies,O
118491,0,:,O
118491,0,Benzodiazepines,B-Drug
118491,0,/,O
118491,0,Furosemide,B-Drug
118491,0,Attending,O
118491,0,:,O
118491,0,[,O
118491,0,*,O
118491,0,*,O
118491,0,First,O
118491,0,Name3,O
118491,0,(,O
118491,0,LF,O
118491,0,),O
118491,0,330,O
118491,0,*,O
118491,0,*,O
118491,0,],O
118491,0,Chief,O
118491,0,Complaint,O
118491,0,:,O
118491,0,Evaluation,O
118491,0,for,O
118491,0,liver,O
118491,0,transplant,O
118491,0,Major,O
118491,0,Surgical,O
118491,0,or,O
118491,0,Invasive,O
118491,0,Procedure,O
118491,0,:,O
118491,0,1,O
118491,0,.,O
118491,0,EGD,O
118491,0,2,O
118491,0,.,O
118491,0,Post-pyloric,O
118491,0,feeding,O
118491,0,tube,O
118491,0,x,O
118491,0,3,O
118491,0,3,O
118491,0,.,O
118491,1,Paracentesis,O
118491,1,4,O
118491,1,.,O
118491,1,PICC,O
118491,1,line,O
118491,1,placement,O
118491,1,x,O
118491,1,2,O
118491,1,History,O
118491,1,of,O
118491,1,Present,O
118491,1,Illness,O
118491,1,:,O
118491,1,45F,O
118491,1,with,O
118491,1,ESLD,O
118491,1,secondary,O
118491,1,to,O
118491,1,EtOH,O
118491,1,",",O
118491,1,AIHA,B-ADE
118491,1,due,O
118491,1,to,O
118491,1,lasix,B-Drug
118491,1,recently,O
118491,1,on,O
118491,1,prednisone,B-Drug
118491,1,who,O
118491,1,was,O
118491,1,initially,O
118491,1,presented,O
118491,1,to,O
118491,1,OSH,O
118491,1,with,O
118491,1,hepatic,O
118491,1,encephalopathy,O
118491,1,transferred,O
118491,1,from,O
118491,1,OSH,O
118491,1,on,O
118491,1,[,O
118491,1,*,O
118491,1,*,O
118491,1,5-27,O
118491,1,*,O
118491,1,*,O
118491,1,],O
118491,1,for,O
118491,1,liver,O
118491,1,transplant,O
118491,1,evaluation,O
118491,1,whose,O
118491,1,course,O
118491,1,has,O
118491,1,been,O
118491,1,complicated,O
118491,1,by,O
118491,1,coagulopathy,O
118491,1,with,O
118491,1,recurrent,O
118491,1,epistaxis,O
118491,1,",",O
118491,1,VRE,O
118491,1,bacteremia,O
118491,1,",",O
118491,1,new,O
118491,1,onset,O
118491,1,Afib,O
118491,1,with,O
118491,1,RVR,O
118491,1,and,O
118491,1,now,O
118491,1,with,O
118491,1,worsening,O
118491,1,leukocytosis,O
118491,1,and,O
118491,1,diffuse,O
118491,1,bilat,O
118491,1,pulmonary,O
118491,1,infiltrates,O
118491,1,.,O
118491,2,.,O
118491,2,To,O
118491,2,summarize,O
118491,2,her,O
118491,2,recent,O
118491,2,course,O
118491,2,",",O
118491,2,the,O
118491,2,patient,O
118491,2,was,O
118491,2,admitted,O
118491,2,to,O
118491,2,OSH,O
118491,2,from,O
118491,2,[,O
118491,2,*,O
118491,2,*,O
118491,2,Date,O
118491,2,range,O
118491,2,(,O
118491,2,1,O
118491,2,),O
118491,2,74368,O
118491,2,*,O
118491,2,*,O
118491,2,],O
118491,2,for,O
118491,2,hemolytic,B-ADE
118491,2,anemia,I-ADE
118491,2,thought,O
118491,2,to,O
118491,2,be,O
118491,2,[,O
118491,2,*,O
118491,2,*,O
118491,2,1-15,O
118491,2,*,O
118491,2,*,O
118491,2,],O
118491,2,lasix,B-Drug
118491,2,and,O
118491,2,was,O
118491,2,started,O
118491,2,on,O
118491,2,prednisone,B-Drug
118491,2,50mg,O
118491,2,.,O
118491,2,On,O
118491,2,[,O
118491,2,*,O
118491,2,*,O
118491,2,5-22,O
118491,2,*,O
118491,2,*,O
118491,2,],O
118491,2,",",O
118491,2,she,O
118491,2,represented,O
118491,2,with,O
118491,2,hepatic,O
118491,2,encephalopathy,O
118491,2,and,O
118491,2,T,O
118491,2,[,O
118491,2,*,O
118491,2,*,O
118491,2,Age,O
118491,2,over,O
118491,2,90,O
118491,2,*,O
118491,2,*,O
118491,2,],O
118491,2,F,O
118491,2,where,O
118491,2,she,O
118491,2,underwent,O
118491,2,paracentesis,O
118491,2,with,O
118491,2,negative,O
118491,2,cultures,O
118491,2,.,O
118491,3,CXR,O
118491,3,showed,O
118491,3,b/l,O
118491,3,infiltrates,O
118491,3,and,O
118491,3,she,O
118491,3,received,O
118491,3,tx,O
118491,3,with,O
118491,3,vanco,B-Drug
118491,3,",",O
118491,3,levoflox,B-Drug
118491,3,",",O
118491,3,and,O
118491,3,zosyn,B-Drug
118491,3,and,O
118491,3,she,O
118491,3,was,O
118491,3,transferred,O
118491,3,to,O
118491,3,[,O
118491,3,*,O
118491,3,*,O
118491,3,Hospital1,O
118491,3,18,O
118491,3,*,O
118491,3,*,O
118491,3,],O
118491,3,for,O
118491,3,liver,O
118491,3,transplant,O
118491,3,eval,O
118491,3,.,O
118491,3,.,O
118491,3,At,O
118491,3,[,O
118491,3,*,O
118491,3,*,O
118491,3,Hospital1,O
118491,3,18,O
118491,3,*,O
118491,3,*,O
118491,3,],O
118491,3,",",O
118491,3,she,O
118491,3,was,O
118491,3,noted,O
118491,3,to,O
118491,3,have,O
118491,3,numerous,O
118491,3,small,O
118491,3,pulmonary,O
118491,3,nodules,O
118491,3,on,O
118491,3,[,O
118491,3,*,O
118491,3,*,O
118491,3,5-29,O
118491,3,*,O
118491,3,*,O
118491,3,],O
118491,3,chest,O
118491,3,CT,O
118491,3,of,O
118491,3,unclear,O
118491,3,significance,O
118491,3,.,O
118491,3,Pulm,O
118491,3,consulted,O
118491,3,for,O
118491,3,?,O
118491,3,bronch,O
118491,3,given,O
118491,3,concern,O
118491,3,for,O
118491,3,infection,O
118491,3,vs.,O
118491,3,malignancy,O
118491,3,.,O
118491,4,Due,O
118491,4,to,O
118491,4,worsening,O
118491,4,confusion,O
118491,4,the,O
118491,4,patient,O
118491,4,underwent,O
118491,4,repeat,O
118491,4,paracentesis,O
118491,4,with,O
118491,4,135,O
118491,4,WBC,O
118491,4,.,O
118491,4,Eventually,O
118491,4,blood,O
118491,4,cultures,O
118491,4,from,O
118491,4,[,O
118491,4,*,O
118491,4,*,O
118491,4,6-11,O
118491,4,*,O
118491,4,*,O
118491,4,],O
118491,4,returned,O
118491,4,[,O
118491,4,*,O
118491,4,*,O
118491,4,12-17,O
118491,4,*,O
118491,4,*,O
118491,4,],O
118491,4,bottles,O
118491,4,+ve,O
118491,4,for,O
118491,4,VRE,B-Reason
118491,4,and,O
118491,4,was,O
118491,4,started,O
118491,4,on,O
118491,4,daptomycin,B-Drug
118491,4,.,O
118491,4,Likely,O
118491,4,source,O
118491,4,was,O
118491,4,colonization,O
118491,4,of,O
118491,4,urine,O
118491,4,discovered,O
118491,4,on,O
118491,4,[,O
118491,4,*,O
118491,4,*,O
118491,4,5-30,O
118491,4,*,O
118491,4,*,O
118491,4,],O
118491,4,.,O
118491,4,Also,O
118491,4,on,O
118491,4,[,O
118491,4,*,O
118491,4,*,O
118491,4,6-11,O
118491,4,*,O
118491,4,*,O
118491,4,],O
118491,4,",",O
118491,4,the,O
118491,4,patient,O
118491,4,was,O
118491,4,started,O
118491,4,on,O
118491,4,CTX,B-Drug
118491,4,for,O
118491,4,positive,O
118491,4,U/A,O
118491,4,which,O
118491,4,was,O
118491,4,then,O
118491,4,continued,O
118491,4,per,O
118491,4,ID,O
118491,4,to,O
118491,4,empirically,O
118491,4,cover,O
118491,4,possible,O
118491,4,SBP,B-Reason
118491,4,.,O
118491,5,Also,O
118491,5,treated,O
118491,5,for,O
118491,5,hepatorenal,B-Reason
118491,5,syndrome,I-Reason
118491,5,(,O
118491,5,cre,O
118491,5,1.5,O
118491,5,which,O
118491,5,improved,O
118491,5,to,O
118491,5,0.4,O
118491,5,),O
118491,5,with,O
118491,5,albumin,B-Drug
118491,5,",",O
118491,5,midodrine,B-Drug
118491,5,",",O
118491,5,and,O
118491,5,octreotide,B-Drug
118491,5,x,O
118491,5,4,O
118491,5,days,O
118491,5,",",O
118491,5,which,O
118491,5,was,O
118491,5,d/c,O
118491,5,'d,O
118491,5,on,O
118491,5,[,O
118491,5,*,O
118491,5,*,O
118491,5,6-16,O
118491,5,*,O
118491,5,*,O
118491,5,],O
118491,5,given,O
118491,5,improvement,O
118491,5,in,O
118491,5,renal,O
118491,5,function,O
118491,5,.,O
118491,5,.,O
118491,5,On,O
118491,5,[,O
118491,5,*,O
118491,5,*,O
118491,5,6-14,O
118491,5,*,O
118491,5,*,O
118491,5,],O
118491,5,",",O
118491,5,the,O
118491,5,patient,O
118491,5,developed,O
118491,5,significant,B-Reason
118491,5,epistaxis,I-Reason
118491,5,requiring,O
118491,5,multiple,O
118491,5,FFP,B-Drug
118491,5,",",O
118491,5,platelet,B-Drug
118491,5,",",O
118491,5,and,O
118491,5,RBC,B-Drug
118491,5,transfusions,O
118491,5,.,O
118491,5,There,O
118491,5,was,O
118491,5,concern,O
118491,5,for,O
118491,5,aspiration,O
118491,5,given,O
118491,5,altered,O
118491,5,mental,O
118491,5,status,O
118491,5,.,O
118491,6,Despite,O
118491,6,continued,O
118491,6,G+,O
118491,6,black,O
118491,6,stools,O
118491,6,her,O
118491,6,Hct,O
118491,6,has,O
118491,6,been,O
118491,6,stable,O
118491,6,since,O
118491,6,[,O
118491,6,*,O
118491,6,*,O
118491,6,6-15,O
118491,6,*,O
118491,6,*,O
118491,6,],O
118491,6,.,O
118491,6,On,O
118491,6,[,O
118491,6,*,O
118491,6,*,O
118491,6,6-16,O
118491,6,*,O
118491,6,*,O
118491,6,],O
118491,6,",",O
118491,6,the,O
118491,6,medical,O
118491,6,team,O
118491,6,repeated,O
118491,6,her,O
118491,6,CT,O
118491,6,chest,O
118491,6,to,O
118491,6,eval,O
118491,6,for,O
118491,6,progression,O
118491,6,of,O
118491,6,pulmonary,O
118491,6,nodules,O
118491,6,and,O
118491,6,found,O
118491,6,bilateral,O
118491,6,infiltrates,O
118491,6,concerning,O
118491,6,for,O
118491,6,infection,O
118491,6,",",O
118491,6,bleeding,O
118491,6,",",O
118491,6,or,O
118491,6,aspiration,O
118491,6,.,O
118491,6,She,O
118491,6,was,O
118491,6,started,O
118491,6,on,O
118491,6,bactrim,B-Drug
118491,6,for,O
118491,6,possible,O
118491,6,PCP,B-Reason
118491,6,given,O
118491,6,her,O
118491,6,recent,O
118491,6,prolonged,O
118491,6,predinsone,B-Drug
118491,6,course,O
118491,6,that,O
118491,6,had,O
118491,6,been,O
118491,6,discontinued,O
118491,6,on,O
118491,6,[,O
118491,6,*,O
118491,6,*,O
118491,6,6-15,O
118491,6,*,O
118491,6,*,O
118491,6,],O
118491,6,.,O
118491,7,Also,O
118491,7,on,O
118491,7,[,O
118491,7,*,O
118491,7,*,O
118491,7,6-16,O
118491,7,*,O
118491,7,*,O
118491,7,],O
118491,7,developed,O
118491,7,new-onset,O
118491,7,Afib,B-Reason
118491,7,with,I-Reason
118491,7,RVR,I-Reason
118491,7,150s,O
118491,7,that,O
118491,7,responded,O
118491,7,to,O
118491,7,diltiazem,B-Drug
118491,7,.,O
118491,7,Due,O
118491,7,to,O
118491,7,increased,O
118491,7,volume,O
118491,7,of,O
118491,7,diarrhea,O
118491,7,and,O
118491,7,climbing,O
118491,7,WBC,O
118491,7,count,O
118491,7,she,O
118491,7,was,O
118491,7,started,O
118491,7,on,O
118491,7,empiric,B-Reason
118491,7,flagyl,B-Drug
118491,7,on,O
118491,7,[,O
118491,7,*,O
118491,7,*,O
118491,7,2106-6-17,O
118491,7,*,O
118491,7,*,O
118491,7,],O
118491,7,.,O
118491,7,.,O
118491,7,On,O
118491,7,transfer,O
118491,7,to,O
118491,7,the,O
118491,7,MICU,O
118491,7,",",O
118491,7,the,O
118491,7,patient,O
118491,7,denies,O
118491,7,any,O
118491,7,complaints,O
118491,7,including,O
118491,7,shortness,O
118491,7,of,O
118491,7,breath,O
118491,7,",",O
118491,7,chest,O
118491,7,pain,O
118491,7,",",O
118491,7,headache,O
118491,7,",",O
118491,7,confusion,O
118491,7,.,O
118491,7,Past,O
118491,7,Medical,O
118491,7,History,O
118491,7,:,O
118491,7,EtOH,O
118491,7,cirrhosis,O
118491,7,s/p,O
118491,7,TIPS,O
118491,7,for,O
118491,7,varices,O
118491,7,in,O
118491,7,[,O
118491,7,*,O
118491,7,*,O
118491,7,2102,O
118491,7,*,O
118491,7,*,O
118491,7,],O
118491,7,with,O
118491,7,multiple,O
118491,7,revisions,O
118491,7,gastric,O
118491,7,varices,O
118491,7,hepatic,O
118491,7,encephalopathy,O
118491,7,spur,O
118491,7,cell,O
118491,7,anemia,O
118491,7,chronic,O
118491,7,hyponatremia,O
118491,7,autoimmune,B-ADE
118491,8,hemolytic,I-ADE
118491,8,anemia,I-ADE
118491,8,(,O
118491,8,from,O
118491,8,lasix,B-Drug
118491,8,?,O
118491,8,),O
118491,8,on,O
118491,8,prednisone,B-Drug
118491,8,h/o,O
118491,8,ovarian,O
118491,8,cysts,O
118491,8,Social,O
118491,8,History,O
118491,8,:,O
118491,8,Lives,O
118491,8,with,O
118491,8,husband,O
118491,8,",",O
118491,8,[,O
118491,8,*,O
118491,8,*,O
118491,8,Name,O
118491,8,(,O
118491,8,NI,O
118491,8,),O
118491,8,*,O
118491,8,*,O
118491,8,],O
118491,8,",",O
118491,8,who,O
118491,8,is,O
118491,8,very,O
118491,8,involved,O
118491,8,in,O
118491,8,her,O
118491,8,care,O
118491,8,.,O
118491,8,No,O
118491,8,children,O
118491,8,.,O
118491,8,No,O
118491,8,tobacco,O
118491,8,use,O
118491,8,ever,O
118491,8,.,O
118491,8,Significant,O
118491,8,EtOH,O
118491,8,history,O
118491,8,",",O
118491,8,sober,O
118491,8,since,O
118491,8,[,O
118491,8,*,O
118491,8,*,O
118491,8,2105-11-28,O
118491,8,*,O
118491,8,*,O
118491,8,],O
118491,8,.,O
118491,8,Involved,O
118491,8,in,O
118491,8,AA,O
118491,8,.,O
118491,8,Reported,O
118491,8,PTSD,O
118491,8,s/p,O
118491,8,attack,O
118491,8,by,O
118491,8,father,O
118491,8,as,O
118491,8,a,O
118491,8,child/teenager,O
118491,8,.,O
118491,8,.,O
118491,8,Previously,O
118491,8,worked,O
118491,8,as,O
118491,8,a,O
118491,8,lawyer,O
118491,8,",",O
118491,8,studied,O
118491,8,at,O
118491,8,[,O
118491,8,*,O
118491,8,*,O
118491,8,Name,O
118491,8,(,O
118491,8,NI,O
118491,8,),O
118491,8,17448,O
118491,8,*,O
118491,8,*,O
118491,8,],O
118491,8,Law,O
118491,8,School,O
118491,8,.,O
118491,9,Family,O
118491,9,History,O
118491,9,:,O
118491,9,No,O
118491,9,liver,O
118491,9,disease,O
118491,9,.,O
118491,9,Alcoholism,O
118491,9,in,O
118491,9,father,O
118491,9,.,O
118491,9,Physical,O
118491,9,Exam,O
118491,9,:,O
118491,9,Admission,O
118491,9,Physical,O
118491,9,Exam,O
118491,9,Vitals,O
118491,9,:,O
118491,9,T,O
118491,9,:,O
118491,9,99.3,O
118491,9,BP,O
118491,9,:,O
118491,9,100/60,O
118491,9,P,O
118491,9,:,O
118491,9,74,O
118491,9,RR,O
118491,9,:,O
118491,9,20,O
118491,9,SpO2,O
118491,9,:,O
118491,9,96,O
118491,9,%,O
118491,9,RA,O
118491,9,wt,O
118491,9,47,O
118491,9,kg,O
118491,9,General,O
118491,9,:,O
118491,9,Awake,O
118491,9,",",O
118491,9,alert,O
118491,9,",",O
118491,9,lying,O
118491,9,flat,O
118491,9,in,O
118491,9,bed,O
118491,9,in,O
118491,9,NAD,O
118491,9,.,O
118491,9,grossly,O
118491,9,jaundiced,O
118491,9,",",O
118491,9,thin,O
118491,9,.,O
118491,9,HEENT,O
118491,9,:,O
118491,9,EOMI,O
118491,9,",",O
118491,9,sclera,O
118491,9,icteric,O
118491,9,.,O
118491,9,MMM,O
118491,9,",",O
118491,9,OP,O
118491,9,without,O
118491,9,lesions,O
118491,9,Neck,O
118491,9,:,O
118491,9,supple,O
118491,9,",",O
118491,9,no,O
118491,9,JVD,O
118491,9,appreciated,O
118491,9,Pulm,O
118491,9,:,O
118491,9,mild,O
118491,9,crackles,O
118491,9,to,O
118491,9,b/t,O
118491,9,bases,O
118491,9,Cardiac,O
118491,9,:,O
118491,9,RRR,O
118491,9,",",O
118491,9,nl,O
118491,9,S1/S2,O
118491,9,",",O
118491,9,2/6,O
118491,9,systolic,O
118491,9,murmur,O
118491,9,Abdomen,O
118491,9,:,O
118491,9,soft,O
118491,9,",",O
118491,9,tender,O
118491,9,to,O
118491,9,deep,O
118491,10,palpation,O
118491,10,to,O
118491,10,epigastrum,O
118491,10,.,O
118491,10,no,O
118491,10,rebound/guarding,O
118491,10,.,O
118491,10,ND,O
118491,10,",",O
118491,10,+,O
118491,10,BS,O
118491,10,",",O
118491,10,no,O
118491,10,hepatomegaly,O
118491,10,noted,O
118491,10,.,O
118491,10,Rectal,O
118491,10,:,O
118491,10,guaiac,O
118491,10,negative,O
118491,10,at,O
118491,10,OSH,O
118491,10,Ext,O
118491,10,:,O
118491,10,No,O
118491,10,edema,O
118491,10,b/t,O
118491,10,",",O
118491,10,warm,O
118491,10,.,O
118491,10,Skin,O
118491,10,:,O
118491,10,spider,O
118491,10,telangiectasias,O
118491,10,to,O
118491,10,chest,O
118491,10,",",O
118491,10,grossly,O
118491,10,jaundiced,O
118491,10,Neurologic,O
118491,10,:,O
118491,10,-mental,O
118491,10,status,O
118491,10,:,O
118491,10,Alert,O
118491,10,&,O
118491,10,Oriented,O
118491,10,x,O
118491,10,3,O
118491,10,.,O
118491,10,Able,O
118491,10,to,O
118491,10,relate,O
118491,10,history,O
118491,10,",",O
118491,10,but,O
118491,10,with,O
118491,10,some,O
118491,10,memory,O
118491,10,lapses,O
118491,10,.,O
118491,10,-cranial,O
118491,10,nerves,O
118491,10,:,O
118491,10,II-XII,O
118491,10,intact,O
118491,10,-motor,O
118491,10,:,O
118491,10,[,O
118491,10,*,O
118491,10,*,O
118491,10,3-18,O
118491,10,*,O
118491,10,*,O
118491,10,],O
118491,10,UE,O
118491,10,strength,O
118491,10,",",O
118491,10,[,O
118491,10,*,O
118491,10,*,O
118491,10,4-17,O
118491,10,*,O
118491,10,*,O
118491,10,],O
118491,10,LE,O
118491,10,.,O
118491,11,-sensory,O
118491,11,:,O
118491,11,No,O
118491,11,deficits,O
118491,11,to,O
118491,11,light,O
118491,11,touch,O
118491,11,throughout,O
118491,11,.,O
118491,11,-no,O
118491,11,asterixis,O
118491,11,.,O
118491,11,ICU,O
118491,11,Admission,O
118491,11,Physical,O
118491,11,Exam,O
118491,11,:,O
118491,11,T,O
118491,11,96.1,O
118491,11,HR,O
118491,11,125,O
118491,11,BP,O
118491,11,113/59,O
118491,11,RR,O
118491,11,23,O
118491,11,SaO2,O
118491,11,98,O
118491,11,%,O
118491,11,on,O
118491,11,RA,O
118491,11,General,O
118491,11,:,O
118491,11,Ill-appearing,O
118491,11,",",O
118491,11,jaundiced,O
118491,11,HEENT,O
118491,11,:,O
118491,11,PERRL,O
118491,11,",",O
118491,11,EOMi,O
118491,11,",",O
118491,11,icteric,O
118491,11,sclera,O
118491,11,",",O
118491,11,mouth,O
118491,11,and,O
118491,11,nares,O
118491,11,with,O
118491,11,crusted,O
118491,11,blood,O
118491,11,",",O
118491,11,OP,O
118491,11,clear,O
118491,11,Neck,O
118491,11,:,O
118491,11,supple,O
118491,11,",",O
118491,11,trachea,O
118491,11,midline,O
118491,11,",",O
118491,11,no,O
118491,11,masses,O
118491,11,",",O
118491,11,no,O
118491,11,LAD,O
118491,11,Cardiac,O
118491,11,:,O
118491,11,tachycardic,O
118491,11,",",O
118491,11,[,O
118491,11,*,O
118491,11,*,O
118491,11,Last,O
118491,11,Name,O
118491,11,(,O
118491,11,un,O
118491,11,),O
118491,11,3526,O
118491,11,*,O
118491,11,*,O
118491,11,],O
118491,11,[,O
118491,11,*,O
118491,11,*,O
118491,11,Last,O
118491,11,Name,O
118491,11,(,O
118491,11,un,O
118491,11,),O
118491,11,3526,O
118491,11,*,O
118491,11,*,O
118491,11,],O
118491,11,",",O
118491,11,s1s2,O
118491,11,normal,O
118491,11,",",O
118491,11,friction,O
118491,11,rub,O
118491,11,noted,O
118491,12,at,O
118491,12,LUSB,O
118491,12,4th,O
118491,12,intercostal,O
118491,12,space,O
118491,12,",",O
118491,12,no,O
118491,12,m/g,O
118491,12,Pulmonary,O
118491,12,:,O
118491,12,bilateral,O
118491,12,crackles,O
118491,12,(,O
118491,12,L,O
118491,12,>,O
118491,12,R,O
118491,12,),O
118491,12,Abdomen,O
118491,12,:,O
118491,12,+BS,O
118491,12,",",O
118491,12,soft,O
118491,12,",",O
118491,12,nontender,O
118491,12,",",O
118491,12,distended,O
118491,12,",",O
118491,12,+ascites,O
118491,12,Extremities,O
118491,12,:,O
118491,12,warm,O
118491,12,",",O
118491,12,2+,O
118491,12,bilateral,O
118491,12,LE,O
118491,12,edema,O
118491,12,Neuro,O
118491,12,:,O
118491,12,A,O
118491,12,&,O
118491,12,Ox3,O
118491,12,",",O
118491,12,speech,O
118491,12,clear,O
118491,12,",",O
118491,12,CNII-XII,O
118491,12,intact,O
118491,12,",",O
118491,12,no,O
118491,12,asterixis,O
118491,12,Pertinent,O
118491,12,Results,O
118491,12,:,O
118491,12,Admission,O
118491,12,Labs,O
118491,12,:,O
118491,12,==============,O
118491,12,[,O
118491,12,*,O
118491,12,*,O
118491,12,2106-5-27,O
118491,12,*,O
118491,12,*,O
118491,12,],O
118491,12,CBC/DIFF,O
118491,12,:,O
118491,12,WBC-19.9,O
118491,12,*,O
118491,12,RBC-2.56,O
118491,12,*,O
118491,12,HGB-9.3,O
118491,12,*,O
118491,12,HCT-24.5,O
118491,12,*,O
118491,12,MCV-96,O
118491,12,MCH-36.3,O
118491,12,*,O
118491,12,MCHC-37.8,O
118491,12,PLT,O
118491,12,39,O
118491,12,NEUTS-91.4,O
118491,12,*,O
118491,12,LYMPHS-4.1,O
118491,12,*,O
118491,12,MONOS-4.3,O
118491,12,EOS-0.1,O
118491,12,BASOS-0.1,O
118491,12,[,O
118491,12,*,O
118491,12,*,O
118491,12,2106-5-27,O
118491,12,*,O
118491,12,*,O
118491,12,],O
118491,12,ALBUMIN-2.4,O
118491,12,*,O
118491,12,CALCIUM-9.5,O
118491,12,PHOSPHATE-2.5,O
118491,12,*,O
118491,12,MAGNESIUM-2.2,O
118491,13,IRON-183,O
118491,13,*,O
118491,13,CHOLEST-92,O
118491,13,[,O
118491,13,*,O
118491,13,*,O
118491,13,2106-5-27,O
118491,13,*,O
118491,13,*,O
118491,13,],O
118491,13,LFTs,O
118491,13,:,O
118491,13,ALT,O
118491,13,(,O
118491,13,SGPT,O
118491,13,),O
118491,13,-51,O
118491,13,*,O
118491,13,AST,O
118491,13,(,O
118491,13,SGOT,O
118491,13,),O
118491,13,-89,O
118491,13,*,O
118491,13,LD,O
118491,13,(,O
118491,13,LDH,O
118491,13,),O
118491,13,-990,O
118491,13,*,O
118491,13,ALK,O
118491,13,PHOS-114,O
118491,13,TOT,O
118491,13,BILI-32.0,O
118491,13,*,O
118491,13,DIR,O
118491,13,BILI-15.2,O
118491,13,*,O
118491,13,INDIR,O
118491,13,BIL-16.8,O
118491,13,[,O
118491,13,*,O
118491,13,*,O
118491,13,2106-5-27,O
118491,13,*,O
118491,13,*,O
118491,13,],O
118491,13,CHEM,O
118491,13,7,O
118491,13,GLUCOSE-101,O
118491,13,UREA,O
118491,13,N-38,O
118491,13,*,O
118491,13,CREAT-0.6,O
118491,13,SODIUM-121,O
118491,13,*,O
118491,13,POTASSIUM-4.0,O
118491,13,CHLORIDE-87,O
118491,13,*,O
118491,13,TOTAL,O
118491,13,CO2-29,O
118491,13,ANION,O
118491,13,GAP-9,O
118491,13,[,O
118491,13,*,O
118491,13,*,O
118491,13,2106-5-27,O
118491,13,*,O
118491,13,*,O
118491,13,],O
118491,13,11:40PM,O
118491,13,PT-23.0,O
118491,13,*,O
118491,13,PTT-49.0,O
118491,13,*,O
118491,13,INR,O
118491,13,(,O
118491,13,PT,O
118491,13,),O
118491,13,-2.3,O
118491,13,*,O
118491,13,.,O
118491,14,Serologies,O
118491,14,:,O
118491,14,==========,O
118491,14,[,O
118491,14,*,O
118491,14,*,O
118491,14,2106-5-27,O
118491,14,*,O
118491,14,*,O
118491,14,],O
118491,14,HCV,O
118491,14,Ab-NEGATIVE,O
118491,14,[,O
118491,14,*,O
118491,14,*,O
118491,14,2106-5-27,O
118491,14,*,O
118491,14,*,O
118491,14,],O
118491,14,HBsAg-NEGATIVE,O
118491,14,HBs,O
118491,14,Ab-POSITIVE,O
118491,14,HBc,O
118491,14,Ab-NEGATIVE,O
118491,14,HAV,O
118491,14,Ab-POSITIVE,O
118491,14,.,O
118491,14,MICRO,O
118491,14,:,O
118491,14,======,O
118491,14,-Blood,O
118491,14,Cultures,O
118491,14,6/15,O
118491,14,",",O
118491,14,[,O
118491,14,*,O
118491,14,*,O
118491,14,5-30,O
118491,14,*,O
118491,14,*,O
118491,14,],O
118491,14,:,O
118491,14,Negative,O
118491,14,-RPR,O
118491,14,non-reactive,O
118491,14,-Rubella,O
118491,14,Immune,O
118491,14,-Varicella,O
118491,14,IgG,O
118491,14,positive,O
118491,14,.,O
118491,14,Lipids,O
118491,14,:,O
118491,14,======,O
118491,14,[,O
118491,14,*,O
118491,14,*,O
118491,14,2106-5-27,O
118491,14,*,O
118491,14,*,O
118491,14,],O
118491,14,LIPIDS,O
118491,14,:,O
118491,14,TRIGLYCER-87,O
118491,14,HDL,O
118491,14,CHOL-45,O
118491,14,CHOL/HDL-2.0,O
118491,14,LDL,O
118491,14,(,O
118491,14,CALC,O
118491,14,),O
118491,14,-30,O
118491,14,.,O
118491,14,IRON,O
118491,14,STUDIES,O
118491,14,:,O
118491,14,TIBC-181,O
118491,14,*,O
118491,14,HAPTOGLOB-,O
118491,14,<,O
118491,14,20,O
118491,14,*,O
118491,14,FERRITIN-1524,O
118491,14,*,O
118491,14,TRF-139,O
118491,14,*,O
118491,14,.,O
118491,15,RADIOLOGY,O
118491,15,:,O
118491,15,=========,O
118491,15,[,O
118491,15,*,O
118491,15,*,O
118491,15,5-28,O
118491,15,*,O
118491,15,*,O
118491,15,],O
118491,15,ABD,O
118491,15,U/S-,O
118491,15,DOPPLER,O
118491,15,LIVER,O
118491,15,ULTRASOUND,O
118491,15,:,O
118491,15,No,O
118491,15,prior,O
118491,15,studies,O
118491,15,are,O
118491,15,available,O
118491,15,for,O
118491,15,comparison,O
118491,15,.,O
118491,15,The,O
118491,15,TIPS,O
118491,15,is,O
118491,15,patent,O
118491,15,with,O
118491,15,wall-to-wall,O
118491,15,color,O
118491,15,flow,O
118491,15,.,O
118491,15,There,O
118491,15,is,O
118491,15,appropriate,O
118491,15,flow,O
118491,15,reversal,O
118491,15,(,O
118491,15,hepatofugal,O
118491,15,),O
118491,15,within,O
118491,15,the,O
118491,15,left,O
118491,15,portal,O
118491,15,vein,O
118491,15,.,O
118491,15,The,O
118491,15,assessment,O
118491,15,of,O
118491,15,the,O
118491,15,right,O
118491,15,anterior,O
118491,15,and,O
118491,15,posterior,O
118491,15,portal,O
118491,15,veins,O
118491,15,was,O
118491,15,limited,O
118491,15,as,O
118491,15,the,O
118491,15,liver,O
118491,15,is,O
118491,15,extremely,O
118491,15,shrunken,O
118491,15,and,O
118491,15,nodular,O
118491,15,.,O
118491,15,The,O
118491,15,following,O
118491,15,velocities,O
118491,15,were,O
118491,15,obtained,O
118491,15,:,O
118491,15,Main,O
118491,15,portal,O
118491,15,vein,O
118491,15,35,O
118491,15,cm/sec,O
118491,15,;,O
118491,15,proximal,O
118491,15,TIPS,O
118491,15,67,O
118491,15,cm/sec,O
118491,15,;,O
118491,15,mid,O
118491,15,TIPS,O
118491,15,73,O
118491,15,cm/sec,O
118491,15,;,O
118491,15,distal,O
118491,15,tips,O
118491,15,74,O
118491,15,cm/sec,O
118491,15,.,O
118491,16,The,O
118491,16,receiving,O
118491,16,hepatic,O
118491,16,vein,O
118491,16,is,O
118491,16,patent,O
118491,16,.,O
118491,16,.,O
118491,16,There,O
118491,16,is,O
118491,16,a,O
118491,16,small,O
118491,16,amount,O
118491,16,of,O
118491,16,ascites,O
118491,16,surrounding,O
118491,16,the,O
118491,16,liver,O
118491,16,",",O
118491,16,relatively,O
118491,16,less,O
118491,16,in,O
118491,16,the,O
118491,16,lower,O
118491,16,quadrants,O
118491,16,.,O
118491,16,The,O
118491,16,liver,O
118491,16,is,O
118491,16,extremely,O
118491,16,shrunken,O
118491,16,and,O
118491,16,nodular,O
118491,16,with,O
118491,16,very,O
118491,16,heterogeneous,O
118491,16,echotexture,O
118491,16,.,O
118491,16,Anterior,O
118491,16,to,O
118491,16,the,O
118491,16,TIPS,O
118491,16,stent,O
118491,16,are,O
118491,16,multiple,O
118491,16,tubular,O
118491,16,hypo-to-anechoic,O
118491,16,structures,O
118491,16,which,O
118491,16,could,O
118491,16,represent,O
118491,16,dilated,O
118491,16,ducts,O
118491,16,or,O
118491,16,less,O
118491,16,likely,O
118491,16,",",O
118491,16,thrombosed,O
118491,16,veins,O
118491,16,.,O
118491,16,No,O
118491,16,frank,O
118491,16,mass,O
118491,16,lesion,O
118491,16,is,O
118491,16,identified,O
118491,16,but,O
118491,16,assessment,O
118491,16,is,O
118491,16,limited,O
118491,16,due,O
118491,16,to,O
118491,16,the,O
118491,16,shrunken,O
118491,16,appearance,O
118491,16,of,O
118491,16,the,O
118491,16,liver,O
118491,16,.,O
118491,17,The,O
118491,17,spleen,O
118491,17,is,O
118491,17,within,O
118491,17,normal,O
118491,17,limits,O
118491,17,in,O
118491,17,size,O
118491,17,measuring,O
118491,17,10.7,O
118491,17,cm,O
118491,17,.,O
118491,17,.,O
118491,17,IMPRESSION,O
118491,17,:,O
118491,17,1,O
118491,17,.,O
118491,17,Patent,O
118491,17,TIPS,O
118491,17,with,O
118491,17,wall-to-wall,O
118491,17,flows,O
118491,17,and,O
118491,17,appropriate,O
118491,17,velocities,O
118491,17,as,O
118491,17,listed,O
118491,17,above,O
118491,17,.,O
118491,17,2,O
118491,17,.,O
118491,17,Shrunken,O
118491,17,cirrhotic,O
118491,17,liver,O
118491,17,without,O
118491,17,overt,O
118491,17,hepatic,O
118491,17,mass,O
118491,17,.,O
118491,17,Questionable,O
118491,17,biliary,O
118491,17,dilatation,O
118491,17,anterior,O
118491,17,to,O
118491,17,TIPS,O
118491,17,stent,O
118491,17,.,O
118491,17,[,O
118491,17,*,O
118491,17,*,O
118491,17,5-29,O
118491,17,*,O
118491,17,*,O
118491,17,],O
118491,17,CT,O
118491,17,A/P-,O
118491,17,IMPRESSION,O
118491,17,:,O
118491,17,1,O
118491,17,.,O
118491,17,Numerous,O
118491,17,noncalcified,O
118491,17,subcentimeter,O
118491,17,nonspecific,O
118491,17,pulmonary,O
118491,17,nodules,O
118491,17,.,O
118491,17,Comparison,O
118491,17,with,O
118491,17,prior,O
118491,17,CT,O
118491,17,scans,O
118491,17,if,O
118491,17,available,O
118491,17,is,O
118491,17,recommended,O
118491,17,to,O
118491,17,evaluate,O
118491,17,for,O
118491,17,stability,O
118491,17,.,O
118491,18,If,O
118491,18,no,O
118491,18,prior,O
118491,18,examinations,O
118491,18,are,O
118491,18,available,O
118491,18,for,O
118491,18,comparison,O
118491,18,",",O
118491,18,and,O
118491,18,the,O
118491,18,patient,O
118491,18,is,O
118491,18,a,O
118491,18,high,O
118491,18,risk,O
118491,18,patient,O
118491,18,i.e,O
118491,18,.,O
118491,18,is,O
118491,18,a,O
118491,18,smoker,O
118491,18,or,O
118491,18,has,O
118491,18,a,O
118491,18,known,O
118491,18,primary,O
118491,18,malignancy,O
118491,18,",",O
118491,18,a,O
118491,18,followup,O
118491,18,with,O
118491,18,CT,O
118491,18,of,O
118491,18,the,O
118491,18,chest,O
118491,18,in,O
118491,18,[,O
118491,18,*,O
118491,18,*,O
118491,18,5-25,O
118491,18,*,O
118491,18,*,O
118491,18,],O
118491,18,months,O
118491,18,is,O
118491,18,recommended,O
118491,18,.,O
118491,18,If,O
118491,18,the,O
118491,18,patient,O
118491,18,is,O
118491,18,at,O
118491,18,low,O
118491,18,risk,O
118491,18,i.e.,O
118491,18,",",O
118491,18,is,O
118491,18,not,O
118491,18,a,O
118491,18,smoker,O
118491,18,or,O
118491,18,has,O
118491,18,no,O
118491,18,known,O
118491,18,malignancy,O
118491,18,",",O
118491,18,followup,O
118491,18,with,O
118491,18,CT,O
118491,18,of,O
118491,18,the,O
118491,18,chest,O
118491,18,in,O
118491,18,twelve,O
118491,18,months,O
118491,18,is,O
118491,18,recommended,O
118491,18,.,O
118491,19,2,O
118491,19,.,O
118491,19,TIPS,O
118491,19,in,O
118491,19,the,O
118491,19,right,O
118491,19,hepatic,O
118491,19,lobe,O
118491,19,.,O
118491,19,3,O
118491,19,.,O
118491,19,Chronic,O
118491,19,occlusion,O
118491,19,of,O
118491,19,the,O
118491,19,left,O
118491,19,portal,O
118491,19,vein,O
118491,19,and,O
118491,19,posterior,O
118491,19,division,O
118491,19,of,O
118491,19,the,O
118491,19,right,O
118491,19,portal,O
118491,19,vein,O
118491,19,with,O
118491,19,corkscrew,O
118491,19,hepatic,O
118491,19,arteries,O
118491,19,which,O
118491,19,are,O
118491,19,patent,O
118491,19,.,O
118491,19,There,O
118491,19,is,O
118491,19,a,O
118491,19,tiny,O
118491,19,left,O
118491,19,hepatic,O
118491,19,artery,O
118491,19,off,O
118491,19,of,O
118491,19,the,O
118491,19,proper,O
118491,19,hepatic,O
118491,19,artery,O
118491,19,with,O
118491,19,an,O
118491,19,accessory,O
118491,19,branch,O
118491,19,off,O
118491,19,the,O
118491,19,left,O
118491,19,gastric,O
118491,19,artery,O
118491,19,.,O
118491,19,No,O
118491,19,suspicious,O
118491,19,hepatic,O
118491,19,lesions,O
118491,19,.,O
118491,19,4,O
118491,19,.,O
118491,19,Moderate,O
118491,19,intraabdominal,O
118491,19,and,O
118491,19,intrapelvic,O
118491,19,ascites,O
118491,19,with,O
118491,19,extensive,O
118491,19,intraabdominal,O
118491,19,varices,O
118491,19,as,O
118491,19,described,O
118491,19,consistent,O
118491,19,with,O
118491,19,portal,O
118491,19,hypertension,O
118491,19,.,O
118491,20,.,O
118491,20,ECHO,O
118491,20,(,O
118491,20,TTE,O
118491,20,),O
118491,20,[,O
118491,20,*,O
118491,20,*,O
118491,20,2106-6-1,O
118491,20,*,O
118491,20,*,O
118491,20,],O
118491,20,-,O
118491,20,Conclusions,O
118491,20,:,O
118491,20,The,O
118491,20,left,O
118491,20,atrium,O
118491,20,is,O
118491,20,mildly,O
118491,20,dilated,O
118491,20,.,O
118491,20,Left,O
118491,20,ventricular,O
118491,20,wall,O
118491,20,thicknesses,O
118491,20,are,O
118491,20,normal,O
118491,20,.,O
118491,20,The,O
118491,20,left,O
118491,20,ventricular,O
118491,20,cavity,O
118491,20,size,O
118491,20,is,O
118491,20,normal,O
118491,20,.,O
118491,20,Regional,O
118491,20,left,O
118491,20,ventricular,O
118491,20,wall,O
118491,20,motion,O
118491,20,is,O
118491,20,normal,O
118491,20,.,O
118491,20,Left,O
118491,20,ventricular,O
118491,20,systolic,O
118491,20,function,O
118491,20,is,O
118491,20,hyperdynamic,O
118491,20,(,O
118491,20,EF,O
118491,20,>,O
118491,20,75,O
118491,20,%,O
118491,20,),O
118491,20,.,O
118491,20,Right,O
118491,20,ventricular,O
118491,20,chamber,O
118491,20,size,O
118491,20,and,O
118491,20,free,O
118491,20,wall,O
118491,20,motion,O
118491,20,are,O
118491,20,normal,O
118491,20,.,O
118491,20,The,O
118491,20,aortic,O
118491,20,valve,O
118491,20,leaflets,O
118491,20,(,O
118491,20,3,O
118491,20,),O
118491,20,appear,O
118491,20,structurally,O
118491,20,normal,O
118491,20,with,O
118491,20,good,O
118491,20,leaflet,O
118491,20,excursion,O
118491,20,.,O
118491,21,There,O
118491,21,is,O
118491,21,no,O
118491,21,valvular,O
118491,21,aortic,O
118491,21,stenosis,O
118491,21,.,O
118491,21,The,O
118491,21,increased,O
118491,21,transaortic,O
118491,21,gradient,O
118491,21,is,O
118491,21,likely,O
118491,21,related,O
118491,21,to,O
118491,21,high,O
118491,21,cardiac,O
118491,21,output,O
118491,21,.,O
118491,21,Trace,O
118491,21,aortic,O
118491,21,regurgitation,O
118491,21,is,O
118491,21,seen,O
118491,21,.,O
118491,21,The,O
118491,21,mitral,O
118491,21,valve,O
118491,21,appears,O
118491,21,structurally,O
118491,21,normal,O
118491,21,with,O
118491,21,trivial,O
118491,21,mitral,O
118491,21,regurgitation,O
118491,21,.,O
118491,21,There,O
118491,21,is,O
118491,21,no,O
118491,21,mitral,O
118491,21,valve,O
118491,21,prolapse,O
118491,21,.,O
118491,21,Mild,O
118491,21,(,O
118491,21,1+,O
118491,21,),O
118491,21,mitral,O
118491,21,regurgitation,O
118491,21,is,O
118491,21,seen,O
118491,21,.,O
118491,21,The,O
118491,21,estimated,O
118491,21,pulmonary,O
118491,21,artery,O
118491,21,systolic,O
118491,21,pressure,O
118491,21,is,O
118491,21,normal,O
118491,21,.,O
118491,21,There,O
118491,21,is,O
118491,21,no,O
118491,21,pericardial,O
118491,21,effusion,O
118491,21,.,O
118491,21,.,O
118491,21,IMPRESSION,O
118491,21,:,O
118491,21,Normal/hyperdynamic,O
118491,21,biventricular,O
118491,21,systolic,O
118491,21,function,O
118491,21,.,O
118491,21,Mild,O
118491,21,mitral,O
118491,21,regurgitation,O
118491,21,.,O
118491,22,Trivial,O
118491,22,aortic,O
118491,22,regurgitation,O
118491,22,.,O
118491,22,.,O
118491,22,Portable,O
118491,22,CXR,O
118491,22,[,O
118491,22,*,O
118491,22,*,O
118491,22,6-4,O
118491,22,*,O
118491,22,*,O
118491,22,],O
118491,22,:,O
118491,22,Cardiomediastinal,O
118491,22,contour,O
118491,22,is,O
118491,22,unchanged,O
118491,22,.,O
118491,22,NG,O
118491,22,tube,O
118491,22,tip,O
118491,22,is,O
118491,22,below,O
118491,22,the,O
118491,22,diaphragm,O
118491,22,out,O
118491,22,of,O
118491,22,view,O
118491,22,.,O
118491,22,Right,O
118491,22,PICC,O
118491,22,line,O
118491,22,tip,O
118491,22,is,O
118491,22,in,O
118491,22,the,O
118491,22,mid,O
118491,22,SVC,O
118491,22,.,O
118491,22,There,O
118491,22,is,O
118491,22,no,O
118491,22,pneumothorax,O
118491,22,.,O
118491,22,New,O
118491,22,ill-defined,O
118491,22,opacity,O
118491,22,in,O
118491,22,the,O
118491,22,left,O
118491,22,lower,O
118491,22,lobe,O
118491,22,in,O
118491,22,the,O
118491,22,retrocardiac,O
118491,22,area,O
118491,22,is,O
118491,22,consistent,O
118491,22,with,O
118491,22,atelectasis,O
118491,22,and/or,O
118491,22,area,O
118491,22,of,O
118491,22,aspiration,O
118491,22,Small,O
118491,22,left,O
118491,22,pleural,O
118491,22,effusion,O
118491,22,is,O
118491,22,also,O
118491,22,new,O
118491,22,.,O
118491,22,.,O
118491,22,CT,O
118491,22,Chest,O
118491,22,[,O
118491,22,*,O
118491,22,*,O
118491,22,6-8,O
118491,22,*,O
118491,22,*,O
118491,22,],O
118491,22,:,O
118491,22,IMPRESSION,O
118491,22,:,O
118491,22,1,O
118491,22,.,O
118491,23,Interim,O
118491,23,improvement,O
118491,23,in,O
118491,23,diffuse,O
118491,23,predominantly,O
118491,23,peribronchiolar,O
118491,23,nodular,O
118491,23,opacities,O
118491,23,",",O
118491,23,though,O
118491,23,numerous,O
118491,23,nodular,O
118491,23,opacities,O
118491,23,persist,O
118491,23,on,O
118491,23,the,O
118491,23,current,O
118491,23,study,O
118491,23,.,O
118491,23,The,O
118491,23,coalescing,O
118491,23,airspace,O
118491,23,disease,O
118491,23,adjacent,O
118491,23,to,O
118491,23,the,O
118491,23,minor,O
118491,23,fissure,O
118491,23,appears,O
118491,23,much,O
118491,23,improved,O
118491,23,.,O
118491,23,Given,O
118491,23,the,O
118491,23,improved,O
118491,23,appearance,O
118491,23,over,O
118491,23,the,O
118491,23,short,O
118491,23,interval,O
118491,23,",",O
118491,23,an,O
118491,23,infectious,O
118491,23,process,O
118491,23,is,O
118491,23,considered,O
118491,23,likely,O
118491,23,.,O
118491,23,Eventual,O
118491,23,CT,O
118491,23,followup,O
118491,23,(,O
118491,23,three,O
118491,23,months,O
118491,23,),O
118491,23,is,O
118491,23,recommended,O
118491,23,after,O
118491,23,treatment,O
118491,23,.,O
118491,23,2,O
118491,23,.,O
118491,23,Small,O
118491,23,bilateral,O
118491,23,pleural,O
118491,23,effusions,O
118491,23,and,O
118491,23,moderate-to-large,O
118491,23,ascites,O
118491,23,as,O
118491,23,well,O
118491,23,as,O
118491,23,subcutaneous,O
118491,23,edema,O
118491,23,are,O
118491,23,unchanged,O
118491,23,from,O
118491,23,the,O
118491,23,prior,O
118491,23,exam,O
118491,23,.,O
118491,24,.,O
118491,24,Abdominal,O
118491,24,U/S,O
118491,24,[,O
118491,24,*,O
118491,24,*,O
118491,24,6-11,O
118491,24,*,O
118491,24,*,O
118491,24,],O
118491,24,:,O
118491,24,IMPRESSION,O
118491,24,:,O
118491,24,1,O
118491,24,.,O
118491,24,Moderate,O
118491,24,to,O
118491,24,large,O
118491,24,amount,O
118491,24,of,O
118491,24,ascites,O
118491,24,.,O
118491,24,A,O
118491,24,spot,O
118491,24,was,O
118491,24,marked,O
118491,24,for,O
118491,24,paracentesis,O
118491,24,to,O
118491,24,be,O
118491,24,performed,O
118491,24,by,O
118491,24,the,O
118491,24,clinical,O
118491,24,service,O
118491,24,.,O
118491,24,2,O
118491,24,.,O
118491,24,_____,O
118491,24,TIPS,O
118491,24,unchanged,O
118491,24,from,O
118491,24,the,O
118491,24,prior,O
118491,24,studies,O
118491,24,.,O
118491,24,3,O
118491,24,.,O
118491,24,Cirrhotic,O
118491,24,liver,O
118491,24,.,O
118491,24,No,O
118491,24,focal,O
118491,24,lesions,O
118491,24,identified,O
118491,24,.,O
118491,24,.,O
118491,24,Portable,O
118491,24,CXR,O
118491,24,[,O
118491,24,*,O
118491,24,*,O
118491,24,6-14,O
118491,24,*,O
118491,24,*,O
118491,24,],O
118491,24,:,O
118491,24,IMPRESSION,O
118491,24,:,O
118491,24,AP,O
118491,24,chest,O
118491,24,compared,O
118491,24,to,O
118491,24,[,O
118491,24,*,O
118491,24,*,O
118491,24,2106-6-12,O
118491,24,*,O
118491,24,*,O
118491,24,],O
118491,24,:,O
118491,24,Pulmonary,O
118491,24,vascular,O
118491,24,congestion,O
118491,24,has,O
118491,24,worsened,O
118491,24,and,O
118491,24,new,O
118491,24,opacification,O
118491,24,at,O
118491,24,the,O
118491,24,lung,O
118491,24,bases,O
118491,24,is,O
118491,24,probably,O
118491,24,a,O
118491,24,combination,O
118491,24,of,O
118491,24,atelectasis,O
118491,24,and,O
118491,25,mild,O
118491,25,edema,O
118491,25,.,O
118491,25,Pleural,O
118491,25,effusion,O
118491,25,is,O
118491,25,small,O
118491,25,",",O
118491,25,on,O
118491,25,the,O
118491,25,left,O
118491,25,",",O
118491,25,unchanged,O
118491,25,acutely,O
118491,25,.,O
118491,25,Heart,O
118491,25,size,O
118491,25,is,O
118491,25,top,O
118491,25,normal,O
118491,25,.,O
118491,25,Left,O
118491,25,PIC,O
118491,25,catheter,O
118491,25,ends,O
118491,25,at,O
118491,25,the,O
118491,25,superior,O
118491,25,cavoatrial,O
118491,25,junction,O
118491,25,.,O
118491,25,Esophageal,O
118491,25,tube,O
118491,25,and,O
118491,25,right,O
118491,25,PIC,O
118491,25,line,O
118491,25,have,O
118491,25,been,O
118491,25,removed,O
118491,25,.,O
118491,25,.,O
118491,25,ECHO,O
118491,25,[,O
118491,25,*,O
118491,25,*,O
118491,25,6-15,O
118491,25,*,O
118491,25,*,O
118491,25,],O
118491,25,:,O
118491,25,Conclusions,O
118491,25,:,O
118491,25,The,O
118491,25,left,O
118491,25,atrium,O
118491,25,is,O
118491,25,elongated,O
118491,25,.,O
118491,25,Left,O
118491,25,ventricular,O
118491,25,wall,O
118491,25,thicknesses,O
118491,25,are,O
118491,25,normal,O
118491,25,.,O
118491,25,The,O
118491,25,left,O
118491,25,ventricular,O
118491,25,cavity,O
118491,25,size,O
118491,25,is,O
118491,25,normal,O
118491,25,.,O
118491,25,Left,O
118491,25,ventricular,O
118491,25,systolic,O
118491,25,function,O
118491,25,is,O
118491,25,hyperdynamic,O
118491,25,(,O
118491,25,EF,O
118491,25,>,O
118491,25,75,O
118491,25,%,O
118491,25,),O
118491,25,.,O
118491,26,There,O
118491,26,is,O
118491,26,no,O
118491,26,ventricular,O
118491,26,septal,O
118491,26,defect,O
118491,26,.,O
118491,26,Right,O
118491,26,ventricular,O
118491,26,chamber,O
118491,26,size,O
118491,26,and,O
118491,26,free,O
118491,26,wall,O
118491,26,motion,O
118491,26,are,O
118491,26,normal,O
118491,26,.,O
118491,26,The,O
118491,26,aortic,O
118491,26,valve,O
118491,26,leaflets,O
118491,26,(,O
118491,26,3,O
118491,26,),O
118491,26,appear,O
118491,26,structurally,O
118491,26,normal,O
118491,26,with,O
118491,26,good,O
118491,26,leaflet,O
118491,26,excursion,O
118491,26,.,O
118491,26,No,O
118491,26,masses,O
118491,26,or,O
118491,26,vegetations,O
118491,26,are,O
118491,26,seen,O
118491,26,on,O
118491,26,the,O
118491,26,aortic,O
118491,26,valve,O
118491,26,.,O
118491,26,There,O
118491,26,is,O
118491,26,no,O
118491,26,valvular,O
118491,26,aortic,O
118491,26,stenosis,O
118491,26,.,O
118491,26,The,O
118491,26,increased,O
118491,26,transaortic,O
118491,26,gradient,O
118491,26,is,O
118491,26,likely,O
118491,26,related,O
118491,26,to,O
118491,26,high,O
118491,26,cardiac,O
118491,26,output,O
118491,26,.,O
118491,26,Mild,O
118491,26,(,O
118491,26,1+,O
118491,26,),O
118491,26,aortic,O
118491,26,regurgitation,O
118491,26,is,O
118491,26,seen,O
118491,26,.,O
118491,26,The,O
118491,26,mitral,O
118491,26,valve,O
118491,26,leaflets,O
118491,26,are,O
118491,26,mildly,O
118491,26,thickened,O
118491,26,.,O
118491,27,There,O
118491,27,is,O
118491,27,no,O
118491,27,mitral,O
118491,27,valve,O
118491,27,prolapse,O
118491,27,.,O
118491,27,No,O
118491,27,mass,O
118491,27,or,O
118491,27,vegetation,O
118491,27,is,O
118491,27,seen,O
118491,27,on,O
118491,27,the,O
118491,27,mitral,O
118491,27,valve,O
118491,27,.,O
118491,27,Trivial,O
118491,27,mitral,O
118491,27,regurgitation,O
118491,27,is,O
118491,27,seen,O
118491,27,.,O
118491,27,There,O
118491,27,is,O
118491,27,moderate,O
118491,27,pulmonary,O
118491,27,artery,O
118491,27,systolic,O
118491,27,hypertension,O
118491,27,.,O
118491,27,No,O
118491,27,vegetation/mass,O
118491,27,is,O
118491,27,seen,O
118491,27,on,O
118491,27,the,O
118491,27,pulmonic,O
118491,27,valve,O
118491,27,.,O
118491,27,There,O
118491,27,is,O
118491,27,no,O
118491,27,pericardial,O
118491,27,effusion,O
118491,27,.,O
118491,27,.,O
118491,27,Compared,O
118491,27,with,O
118491,27,the,O
118491,27,findings,O
118491,27,of,O
118491,27,the,O
118491,27,prior,O
118491,27,study,O
118491,27,(,O
118491,27,images,O
118491,27,reviewed,O
118491,27,),O
118491,27,of,O
118491,27,[,O
118491,27,*,O
118491,27,*,O
118491,27,2106-6-1,O
118491,27,*,O
118491,27,*,O
118491,27,],O
118491,27,",",O
118491,27,the,O
118491,27,tricuspid,O
118491,27,regurgitation,O
118491,27,is,O
118491,27,somewhat,O
118491,27,increased,O
118491,27,.,O
118491,28,.,O
118491,28,If,O
118491,28,clinically,O
118491,28,suggested,O
118491,28,",",O
118491,28,the,O
118491,28,absence,O
118491,28,of,O
118491,28,a,O
118491,28,vegetation,O
118491,28,by,O
118491,28,2D,O
118491,28,echocardiography,O
118491,28,does,O
118491,28,not,O
118491,28,exclude,O
118491,28,endocarditis,O
118491,28,.,O
118491,28,.,O
118491,28,[,O
118491,28,*,O
118491,28,*,O
118491,28,6-16,O
118491,28,*,O
118491,28,*,O
118491,28,],O
118491,28,Chest,O
118491,28,CT,O
118491,28,FINDINGS,O
118491,28,:,O
118491,28,Since,O
118491,28,the,O
118491,28,prior,O
118491,28,study,O
118491,28,there,O
118491,28,has,O
118491,28,been,O
118491,28,marked,O
118491,28,worsening,O
118491,28,of,O
118491,28,the,O
118491,28,alveolar,O
118491,28,opacities,O
118491,28,involving,O
118491,28,both,O
118491,28,lungs,O
118491,28,",",O
118491,28,predominantly,O
118491,28,in,O
118491,28,the,O
118491,28,upper,O
118491,28,zones,O
118491,28,.,O
118491,28,The,O
118491,28,periphery,O
118491,28,of,O
118491,28,the,O
118491,28,lungs,O
118491,28,is,O
118491,28,relatively,O
118491,28,spared,O
118491,28,.,O
118491,28,There,O
118491,28,are,O
118491,28,small,O
118491,28,bilateral,O
118491,28,pleural,O
118491,28,effusions,O
118491,28,.,O
118491,28,The,O
118491,28,heart,O
118491,28,size,O
118491,28,appears,O
118491,28,slightly,O
118491,28,enlarged,O
118491,28,.,O
118491,29,There,O
118491,29,is,O
118491,29,no,O
118491,29,pericardial,O
118491,29,effusion,O
118491,29,.,O
118491,29,There,O
118491,29,are,O
118491,29,borderline,O
118491,29,lymph,O
118491,29,nodes,O
118491,29,in,O
118491,29,the,O
118491,29,paratracheal,O
118491,29,region,O
118491,29,measuring,O
118491,29,up,O
118491,29,to,O
118491,29,9,O
118491,29,mm,O
118491,29,in,O
118491,29,short,O
118491,29,axis,O
118491,29,.,O
118491,29,The,O
118491,29,central,O
118491,29,airways,O
118491,29,are,O
118491,29,patent,O
118491,29,without,O
118491,29,endoluminal,O
118491,29,lesions,O
118491,29,.,O
118491,29,A,O
118491,29,left-sided,O
118491,29,PICC,O
118491,29,is,O
118491,29,seen,O
118491,29,extending,O
118491,29,into,O
118491,29,the,O
118491,29,superior,O
118491,29,vena,O
118491,29,cava,O
118491,29,.,O
118491,29,.,O
118491,29,In,O
118491,29,the,O
118491,29,visualized,O
118491,29,upper,O
118491,29,abdomen,O
118491,29,again,O
118491,29,seen,O
118491,29,is,O
118491,29,a,O
118491,29,cirrhotic,O
118491,29,liver,O
118491,29,with,O
118491,29,the,O
118491,29,TIPS,O
118491,29,shunt,O
118491,29,in,O
118491,29,place,O
118491,29,.,O
118491,29,There,O
118491,29,is,O
118491,29,a,O
118491,29,large,O
118491,29,amount,O
118491,29,of,O
118491,29,ascites,O
118491,29,noted,O
118491,29,.,O
118491,29,Coils,O
118491,29,are,O
118491,29,noted,O
118491,29,in,O
118491,29,the,O
118491,29,region,O
118491,29,of,O
118491,29,the,O
118491,29,splenic,O
118491,29,vessels,O
118491,29,.,O
118491,30,The,O
118491,30,osseous,O
118491,30,structures,O
118491,30,appear,O
118491,30,unremarkable,O
118491,30,.,O
118491,30,.,O
118491,30,IMPRESSION,O
118491,30,:,O
118491,30,1,O
118491,30,.,O
118491,30,Marked,O
118491,30,worsening,O
118491,30,of,O
118491,30,bilateral,O
118491,30,extensive,O
118491,30,alveolar,O
118491,30,opacities,O
118491,30,particularly,O
118491,30,centrally,O
118491,30,.,O
118491,30,The,O
118491,30,rapidity,O
118491,30,of,O
118491,30,development,O
118491,30,and,O
118491,30,distribution,O
118491,30,is,O
118491,30,most,O
118491,30,concerning,O
118491,30,for,O
118491,30,pulmonary,O
118491,30,edema,O
118491,30,",",O
118491,30,however,O
118491,30,",",O
118491,30,atypical,O
118491,30,infection,O
118491,30,or,O
118491,30,less,O
118491,30,likely,O
118491,30,pulmonary,O
118491,30,hemorrhage,O
118491,30,can,O
118491,30,not,O
118491,30,be,O
118491,30,excluded,O
118491,30,.,O
118491,30,Small,O
118491,30,bilateral,O
118491,30,pleural,O
118491,30,effusions,O
118491,30,.,O
118491,30,2,O
118491,30,.,O
118491,30,Cirrhotic,O
118491,30,liver,O
118491,30,with,O
118491,30,a,O
118491,30,moderate,O
118491,30,amount,O
118491,30,of,O
118491,30,ascites,O
118491,30,and,O
118491,30,TIPS,O
118491,30,shunt,O
118491,30,in,O
118491,30,place,O
118491,30,.,O
118491,30,.,O
118491,30,OTHER,O
118491,30,STUDIES,O
118491,30,:,O
118491,30,==============,O
118491,30,EGD,O
118491,30,[,O
118491,30,*,O
118491,30,*,O
118491,30,2106-6-2,O
118491,30,*,O
118491,30,*,O
118491,30,],O
118491,30,-,O
118491,30,Grade,O
118491,30,1,O
118491,30,esophageal,O
118491,30,varices,O
118491,30,A,O
118491,30,trans-endoscopic,O
118491,30,NJ,O
118491,30,feeding,O
118491,30,tube,O
118491,30,(,O
118491,30,8,O
118491,30,fr,O
118491,30,),O
118491,30,was,O
118491,30,placed,O
118491,30,to,O
118491,30,120,O
118491,31,cm,O
118491,31,.,O
118491,31,Otherwise,O
118491,31,normal,O
118491,31,EGD,O
118491,31,to,O
118491,31,second,O
118491,31,part,O
118491,31,of,O
118491,31,duodenum,O
118491,31,.,O
118491,31,Brief,O
118491,31,Hospital,O
118491,31,Course,O
118491,31,:,O
118491,31,45,O
118491,31,yo,O
118491,31,female,O
118491,31,with,O
118491,31,ESLD,O
118491,31,[,O
118491,31,*,O
118491,31,*,O
118491,31,1-15,O
118491,31,*,O
118491,31,*,O
118491,31,],O
118491,31,EtOH,O
118491,31,cirrhosis,O
118491,31,s/p,O
118491,31,TIPS,O
118491,31,who,O
118491,31,presented,O
118491,31,from,O
118491,31,OSH,O
118491,31,for,O
118491,31,liver,O
118491,31,transplant,O
118491,31,evaluation,O
118491,31,",",O
118491,31,recent,O
118491,31,severe,O
118491,31,bleeding,O
118491,31,",",O
118491,31,who,O
118491,31,developed,O
118491,31,sepsis,O
118491,31,",",O
118491,31,DIC,O
118491,31,",",O
118491,31,and,O
118491,31,multiorgan,O
118491,31,failure,O
118491,31,.,O
118491,31,A,O
118491,31,brief,O
118491,31,hospital,O
118491,31,course,O
118491,31,by,O
118491,31,problem,O
118491,31,is,O
118491,31,outlined,O
118491,31,below,O
118491,31,:,O
118491,31,.,O
118491,31,#,O
118491,31,Sepsis,B-Reason
118491,31,/,O
118491,31,DIC,B-Reason
118491,31,:,O
118491,31,The,O
118491,31,patient,O
118491,31,required,O
118491,31,multiple,O
118491,31,vasopressors,B-Drug
118491,31,to,O
118491,31,maintain,O
118491,31,SvO2,O
118491,31,>,O
118491,31,70,O
118491,31,and,O
118491,31,MAP,O
118491,31,>,O
118491,31,60s,O
118491,31,.,O
118491,32,Lactate,O
118491,32,continued,O
118491,32,to,O
118491,32,rise,O
118491,32,and,O
118491,32,she,O
118491,32,became,O
118491,32,progressively,O
118491,32,acidotic,O
118491,32,.,O
118491,32,End,O
118491,32,organ,O
118491,32,hypoperfusion,O
118491,32,was,O
118491,32,demonstrated,O
118491,32,by,O
118491,32,anuria,O
118491,32,.,O
118491,32,She,O
118491,32,was,O
118491,32,treated,O
118491,32,broadly,O
118491,32,with,O
118491,32,antibiotics,B-Drug
118491,32,and,O
118491,32,aggressively,O
118491,32,transfused,O
118491,32,with,O
118491,32,blood,B-Drug
118491,32,products,I-Drug
118491,32,and,O
118491,32,albumin,B-Drug
118491,32,for,O
118491,32,intravascular,B-Reason
118491,32,volume,I-Reason
118491,32,support,I-Reason
118491,32,and,O
118491,32,to,O
118491,32,correct,B-Reason
118491,32,her,I-Reason
118491,32,underlying,I-Reason
118491,32,coagulopathy,I-Reason
118491,32,.,O
118491,32,HCO3,B-Drug
118491,32,was,O
118491,32,utilized,O
118491,32,prn,O
118491,32,given,O
118491,32,worsening,O
118491,32,acidosis,B-Reason
118491,32,.,O
118491,32,The,O
118491,32,patient,O
118491,32,was,O
118491,32,made,O
118491,32,CMO,O
118491,32,after,O
118491,32,an,O
118491,32,extensive,O
118491,32,family,O
118491,32,discussion,O
118491,32,regarding,O
118491,32,her,O
118491,32,poor,O
118491,32,prognosis,O
118491,32,and,O
118491,32,she,O
118491,32,rapidly,O
118491,32,expired,O
118491,32,after,O
118491,32,removal,O
118491,32,of,O
118491,32,vasopressors,B-Drug
118491,32,and,O
118491,32,respiratory,O
118491,32,support,O
118491,32,.,O
118491,33,.,O
118491,33,#,O
118491,33,Respiratory,O
118491,33,Failure,O
118491,33,:,O
118491,33,Progressively,O
118491,33,worsening,O
118491,33,bilateral,O
118491,33,lung,O
118491,33,infiltrates,O
118491,33,resulting,O
118491,33,in,O
118491,33,hypoxia,O
118491,33,requiring,O
118491,33,intubation,O
118491,33,.,O
118491,33,Differential,O
118491,33,included,O
118491,33,DAH,O
118491,33,given,O
118491,33,coagulopathy,O
118491,33,",",O
118491,33,infection,B-ADE
118491,33,(,O
118491,33,e.g,O
118491,33,.,O
118491,33,PCP/fungal,O
118491,33,given,O
118491,33,recent,O
118491,33,course,O
118491,33,of,O
118491,33,steroids,B-Drug
118491,33,),O
118491,33,",",O
118491,33,or,O
118491,33,TRALI,O
118491,33,(,O
118491,33,though,O
118491,33,unlikely,O
118491,33,),O
118491,33,.,O
118491,33,She,O
118491,33,was,O
118491,33,afebrile,O
118491,33,with,O
118491,33,rapidly,O
118491,33,progressive,O
118491,33,leukocytosis,O
118491,33,.,O
118491,33,The,O
118491,33,patient,O
118491,33,was,O
118491,33,treated,O
118491,33,with,O
118491,33,steroids,B-Drug
118491,33,and,O
118491,33,bactrim,B-Drug
118491,33,for,O
118491,33,PCP,B-Reason
118491,33,",",O
118491,33,[,O
118491,33,*,O
118491,33,*,O
118491,33,Name10,O
118491,33,(,O
118491,33,NameIs,O
118491,33,),O
118491,33,74369,O
118491,33,*,O
118491,33,*,O
118491,33,],O
118491,33,for,O
118491,33,fungal,O
118491,33,coverage,O
118491,33,",",O
118491,33,and,O
118491,33,levaquin,B-Drug
118491,33,to,O
118491,33,cover,O
118491,33,mycoplasma,B-Reason
118491,33,",",O
118491,33,and,O
118491,33,flagyl,B-Drug
118491,33,for,O
118491,33,anaerobic,B-Reason
118491,33,coverage,I-Reason
118491,33,.,O
118491,34,Given,O
118491,34,worsening,O
118491,34,infiltrates,O
118491,34,and,O
118491,34,P/F,O
118491,34,ratio,O
118491,34,suggestive,O
118491,34,of,O
118491,34,ARDS,O
118491,34,",",O
118491,34,she,O
118491,34,was,O
118491,34,ventilated,O
118491,34,on,O
118491,34,ARDSnet,O
118491,34,protocol,O
118491,34,to,O
118491,34,minimize,O
118491,34,barotrauma,O
118491,34,and,O
118491,34,allowed,O
118491,34,permissive,O
118491,34,hypercapnea,O
118491,34,.,O
118491,34,.,O
118491,34,#,O
118491,34,Acute,O
118491,34,renal,O
118491,34,failure,O
118491,34,:,O
118491,34,Cr,O
118491,34,progressively,O
118491,34,worsened,O
118491,34,in,O
118491,34,the,O
118491,34,setting,O
118491,34,of,O
118491,34,sepsis,O
118491,34,and,O
118491,34,the,O
118491,34,patient,O
118491,34,became,O
118491,34,anuric,O
118491,34,.,O
118491,34,Differential,O
118491,34,included,O
118491,34,HRS,O
118491,34,",",O
118491,34,ATN,O
118491,34,[,O
118491,34,*,O
118491,34,*,O
118491,34,1-15,O
118491,34,*,O
118491,34,*,O
118491,34,],O
118491,34,renal,O
118491,34,hypoperfusion,O
118491,34,",",O
118491,34,prerenal,O
118491,34,[,O
118491,34,*,O
118491,34,*,O
118491,34,1-15,O
118491,34,*,O
118491,34,*,O
118491,34,],O
118491,34,hypoalbuminemia,O
118491,34,and,O
118491,34,3rd,O
118491,34,spacing,O
118491,34,.,O
118491,34,She,O
118491,34,was,O
118491,34,unable,O
118491,34,to,O
118491,34,take,O
118491,34,po,O
118491,34,octreotide,B-Drug
118491,34,",",O
118491,34,midodrine,B-Drug
118491,34,due,O
118491,34,to,O
118491,34,increased,B-ADE
118491,34,GI,I-ADE
118491,34,secretions,I-ADE
118491,34,and,O
118491,34,poor,O
118491,34,absorption,O
118491,34,.,O
118491,35,Attempted,O
118491,35,to,O
118491,35,increased,O
118491,35,intravascular,B-Reason
118491,35,volume,I-Reason
118491,35,with,O
118491,35,albumin,B-Drug
118491,35,and,O
118491,35,blood,B-Drug
118491,35,products,I-Drug
118491,35,.,I-Drug
118491,35,Pressors,B-Drug
118491,35,were,O
118491,35,utilized,O
118491,35,to,O
118491,35,maintain,O
118491,35,renal,B-Reason
118491,35,perfusion,I-Reason
118491,35,.,O
118491,35,The,O
118491,35,patient,O
118491,35,developed,O
118491,35,a,O
118491,35,severe,B-Reason
118491,35,lactic,I-Reason
118491,35,acid,I-Reason
118491,35,metabolic,I-Reason
118491,35,acidosis,I-Reason
118491,35,due,O
118491,35,to,O
118491,35,tissue,O
118491,35,hypoxia,O
118491,35,requiring,O
118491,35,HCO3,B-Drug
118491,35,pushes,O
118491,35,.,O
118491,35,.,O
118491,35,#,O
118491,35,ETOH,O
118491,35,Cirrhosis,O
118491,35,:,O
118491,35,Decompensated,O
118491,35,liver,O
118491,35,disease,O
118491,35,s/p,O
118491,35,TIPS,O
118491,35,",",O
118491,35,with,O
118491,35,hepatic,O
118491,35,encephalopathy,O
118491,35,",",O
118491,35,coagluapathy,O
118491,35,",",O
118491,35,elevated,O
118491,35,Tbili,O
118491,35,",",O
118491,35,hyponatremia,O
118491,35,.,O
118491,35,On,O
118491,35,admission,O
118491,35,",",O
118491,35,aldactone,B-Drug
118491,35,held,O
118491,35,given,O
118491,35,hyponatremia,B-ADE
118491,35,and,O
118491,35,hypotension,B-ADE
118491,35,.,O
118491,35,Lasix,B-Drug
118491,35,held,O
118491,35,given,O
118491,35,auto-immune,B-ADE
118491,35,hemolytic,I-ADE
118491,35,anemia,I-ADE
118491,35,.,O
118491,35,She,O
118491,35,was,O
118491,35,given,O
118491,35,lactulose,B-Drug
118491,35,and,O
118491,35,rifaxamin,B-Drug
118491,35,for,O
118491,35,hepatic,B-Reason
118491,35,encephalopathy,I-Reason
118491,35,.,O
118491,36,Ultrasound,O
118491,36,perfomed,O
118491,36,on,O
118491,36,admission,O
118491,36,and,O
118491,36,showed,O
118491,36,patent,O
118491,36,TIPS,O
118491,36,",",O
118491,36,cirrhotic,O
118491,36,liver,O
118491,36,",",O
118491,36,no,O
118491,36,hepatoma,O
118491,36,.,O
118491,36,Diagnostic,O
118491,36,paracentesis,O
118491,36,was,O
118491,36,performed,O
118491,36,",",O
118491,36,and,O
118491,36,was,O
118491,36,negative,O
118491,36,for,O
118491,36,SBP,O
118491,36,.,O
118491,36,.,O
118491,36,During,O
118491,36,hospitalization,O
118491,36,",",O
118491,36,she,O
118491,36,was,O
118491,36,evaluated,O
118491,36,for,O
118491,36,liver,O
118491,36,transplant,O
118491,36,",",O
118491,36,and,O
118491,36,was,O
118491,36,transiently,O
118491,36,placed,O
118491,36,on,O
118491,36,the,O
118491,36,transplant,O
118491,36,list,O
118491,36,but,O
118491,36,was,O
118491,36,removed,O
118491,36,after,O
118491,36,becoming,O
118491,36,septic,O
118491,36,.,O
118491,36,TTE,O
118491,36,showed,O
118491,36,a,O
118491,36,hyperdynamic,O
118491,36,EF,O
118491,36,",",O
118491,36,with,O
118491,36,no,O
118491,36,pulmonary,O
118491,36,hypertension,O
118491,36,or,O
118491,36,significant,O
118491,36,valvular,O
118491,36,disease,O
118491,36,.,O
118491,36,Liver,O
118491,36,CT,O
118491,36,completed,O
118491,36,.,O
118491,36,PFT,O
118491,36,'s,O
118491,36,performed,O
118491,36,",",O
118491,36,with,O
118491,36,noted,O
118491,36,mild,O
118491,36,diffusion,O
118491,36,abnormality,O
118491,36,.,O
118491,37,Chest,O
118491,37,CT,O
118491,37,demonstrated,O
118491,37,pulmonary,O
118491,37,nodules,O
118491,37,(,O
118491,37,see,O
118491,37,below,O
118491,37,),O
118491,37,which,O
118491,37,were,O
118491,37,stable,O
118491,37,on,O
118491,37,repeat,O
118491,37,CT,O
118491,37,chest,O
118491,37,one,O
118491,37,week,O
118491,37,later,O
118491,37,.,O
118491,37,Chest,O
118491,37,CT,O
118491,37,from,O
118491,37,[,O
118491,37,*,O
118491,37,*,O
118491,37,2106-6-16,O
118491,37,*,O
118491,37,*,O
118491,37,],O
118491,37,showed,O
118491,37,marked,O
118491,37,worsening,O
118491,37,(,O
118491,37,see,O
118491,37,below,O
118491,37,),O
118491,37,.,O
118491,37,.,O
118491,37,Hospitalization,O
118491,37,was,O
118491,37,complicated,O
118491,37,by,O
118491,37,hepatic,O
118491,37,encephalopathy,O
118491,37,",",O
118491,37,hyponatremia,O
118491,37,and,O
118491,37,hepatorenal,O
118491,37,syndrome,O
118491,37,.,O
118491,37,HRS,B-Reason
118491,37,improved,O
118491,37,after,O
118491,37,midodrine,B-Drug
118491,37,and,O
118491,37,octreotide,B-Drug
118491,37,",",O
118491,37,and,O
118491,37,albumin,B-Drug
118491,37,steadied,O
118491,37,hyponatremia,B-Reason
118491,37,near,O
118491,37,baseline,O
118491,37,of,O
118491,37,127-129,O
118491,37,.,O
118491,37,She,O
118491,37,was,O
118491,37,fluid,O
118491,37,restricted,O
118491,37,",",O
118491,37,but,O
118491,37,continued,O
118491,37,to,O
118491,37,have,O
118491,37,worsening,O
118491,37,peripheral,O
118491,37,edema,O
118491,37,;,O
118491,37,diuretics,O
118491,37,were,O
118491,37,held,O
118491,37,given,O
118491,37,her,O
118491,37,recently,O
118491,37,diagnosed,O
118491,37,AIHA,B-ADE
118491,37,[,O
118491,37,*,O
118491,37,*,O
118491,37,1-15,O
118491,37,*,O
118491,37,*,O
118491,37,],O
118491,37,lasix,B-Drug
118491,37,.,O
118491,38,.,O
118491,38,#,O
118491,38,Arrhythmia,O
118491,38,:,O
118491,38,The,O
118491,38,patient,O
118491,38,had,O
118491,38,two,O
118491,38,asymptomatic,O
118491,38,episodes,O
118491,38,of,O
118491,38,stable,O
118491,38,Vtach,O
118491,38,on,O
118491,38,the,O
118491,38,floor,O
118491,38,.,O
118491,38,On,O
118491,38,[,O
118491,38,*,O
118491,38,*,O
118491,38,2106-6-16,O
118491,38,*,O
118491,38,*,O
118491,38,],O
118491,38,",",O
118491,38,pt,O
118491,38,developed,O
118491,38,atrial,O
118491,38,fibrillation,O
118491,38,to,O
118491,38,160,O
118491,38,'s,O
118491,38,.,O
118491,38,She,O
118491,38,was,O
118491,38,converted,O
118491,38,with,O
118491,38,lopressor,B-Drug
118491,38,and,O
118491,38,diltiazam,B-Drug
118491,38,",",O
118491,38,but,O
118491,38,then,O
118491,38,reverted,O
118491,38,to,O
118491,38,Afib/flutter,B-Reason
118491,38,rate-controlled,I-Reason
118491,38,on,O
118491,38,diltiazem,B-Drug
118491,38,.,O
118491,38,On,O
118491,38,transfer,O
118491,38,to,O
118491,38,the,O
118491,38,MICU,O
118491,38,",",O
118491,38,she,O
118491,38,had,O
118491,38,bursts,O
118491,38,of,O
118491,38,atrial,O
118491,38,flutter,O
118491,38,with,O
118491,38,variable,O
118491,38,block,O
118491,38,and,O
118491,38,rate-dependent,O
118491,38,bundle,O
118491,38,branch,O
118491,38,block,O
118491,38,.,O
118491,38,She,O
118491,38,remained,O
118491,38,asymptomatic,O
118491,38,but,O
118491,38,nodal,O
118491,38,agents,O
118491,38,were,O
118491,38,held,O
118491,38,given,O
118491,38,hypotension,O
118491,38,.,O
118491,39,.,O
118491,39,#,O
118491,39,Leukocytosis,O
118491,39,:,O
118491,39,Initially,O
118491,39,with,O
118491,39,nosocomial,O
118491,39,pneumonia,O
118491,39,at,O
118491,39,outside,O
118491,39,hospital,O
118491,39,treated,O
118491,39,with,O
118491,39,a,O
118491,39,course,O
118491,39,of,O
118491,39,IV,O
118491,39,antibiotics,B-Drug
118491,39,.,O
118491,39,Upon,O
118491,39,admission,O
118491,39,to,O
118491,39,[,O
118491,39,*,O
118491,39,*,O
118491,39,Hospital1,O
118491,39,18,O
118491,39,*,O
118491,39,*,O
118491,39,],O
118491,39,",",O
118491,39,no,O
118491,39,infectious,O
118491,39,etiology,O
118491,39,was,O
118491,39,found,O
118491,39,",",O
118491,39,with,O
118491,39,negative,O
118491,39,blood,O
118491,39,",",O
118491,39,urine,O
118491,39,and,O
118491,39,stool,O
118491,39,cultures,O
118491,39,.,O
118491,39,Although,O
118491,39,pulmonary,O
118491,39,nodules,O
118491,39,were,O
118491,39,seen,O
118491,39,on,O
118491,39,chest,O
118491,39,CT,O
118491,39,",",O
118491,39,this,O
118491,39,was,O
118491,39,not,O
118491,39,felt,O
118491,39,to,O
118491,39,represent,O
118491,39,an,O
118491,39,acute,O
118491,39,infectious,O
118491,39,process,O
118491,39,given,O
118491,39,lack,O
118491,39,of,O
118491,39,associated,O
118491,39,signs,O
118491,39,or,O
118491,39,symptoms,O
118491,39,of,O
118491,39,infection,O
118491,39,",",O
118491,39,therefore,O
118491,39,no,O
118491,39,further,O
118491,39,antibiotics,O
118491,39,were,O
118491,39,given,O
118491,39,.,O
118491,40,Acute,O
118491,40,alcoholic,O
118491,40,hepatitis,O
118491,40,was,O
118491,40,considered,O
118491,40,as,O
118491,40,a,O
118491,40,possible,O
118491,40,cause,O
118491,40,of,O
118491,40,leukocytosis,O
118491,40,",",O
118491,40,however,O
118491,40,there,O
118491,40,was,O
118491,40,no,O
118491,40,recent,O
118491,40,alcohol,O
118491,40,use,O
118491,40,to,O
118491,40,go,O
118491,40,along,O
118491,40,with,O
118491,40,this,O
118491,40,diagnosis,O
118491,40,.,O
118491,40,.,O
118491,40,On,O
118491,40,[,O
118491,40,*,O
118491,40,*,O
118491,40,6-5,O
118491,40,*,O
118491,40,*,O
118491,40,],O
118491,40,",",O
118491,40,UCx,O
118491,40,with,O
118491,40,VRE,O
118491,40,.,O
118491,40,On,O
118491,40,[,O
118491,40,*,O
118491,40,*,O
118491,40,6-11,O
118491,40,*,O
118491,40,*,O
118491,40,],O
118491,40,",",O
118491,40,pt,O
118491,40,'s,O
118491,40,blood,O
118491,40,cultures,O
118491,40,positive,O
118491,40,for,O
118491,40,VRE,B-Reason
118491,40,.,O
118491,40,Felt,O
118491,40,that,O
118491,40,PICC,O
118491,40,line,O
118491,40,was,O
118491,40,possible,O
118491,40,source,O
118491,40,;,O
118491,40,however,O
118491,40,",",O
118491,40,wound,O
118491,40,tip,O
118491,40,culture,O
118491,40,showed,O
118491,40,no,O
118491,40,growth,O
118491,40,.,O
118491,40,She,O
118491,40,was,O
118491,40,started,O
118491,40,on,O
118491,40,daptomycin,B-Drug
118491,40,and,O
118491,40,ceftriaxone,B-Drug
118491,40,per,O
118491,40,ID,O
118491,40,.,O
118491,41,Echocardiogram,O
118491,41,was,O
118491,41,negative,O
118491,41,for,O
118491,41,vegetation,O
118491,41,.,O
118491,41,On,O
118491,41,[,O
118491,41,*,O
118491,41,*,O
118491,41,6-16,O
118491,41,*,O
118491,41,*,O
118491,41,],O
118491,41,",",O
118491,41,a,O
118491,41,repeat,O
118491,41,chest,O
118491,41,CT,O
118491,41,was,O
118491,41,performed,O
118491,41,for,O
118491,41,further,O
118491,41,characterization,O
118491,41,of,O
118491,41,pulmonary,O
118491,41,nodules,O
118491,41,which,O
118491,41,revealed,O
118491,41,the,O
118491,41,interval,O
118491,41,development,O
118491,41,of,O
118491,41,diffuse,O
118491,41,hazy,O
118491,41,opacities,O
118491,41,thought,O
118491,41,to,O
118491,41,be,O
118491,41,consistent,O
118491,41,with,O
118491,41,PCP,O
118491,41,",",O
118491,41,[,O
118491,41,*,O
118491,41,*,O
118491,41,Name10,O
118491,41,(,O
118491,41,NameIs,O
118491,41,),O
118491,41,7470,O
118491,41,*,O
118491,41,*,O
118491,41,],O
118491,41,given,O
118491,41,that,O
118491,41,she,O
118491,41,was,O
118491,41,weaned,O
118491,41,off,O
118491,41,steroids,B-Drug
118491,41,for,O
118491,41,AIHA,B-Reason
118491,41,only,O
118491,41,days,O
118491,41,earlier,O
118491,41,.,O
118491,41,She,O
118491,41,was,O
118491,41,started,O
118491,41,emperically,O
118491,41,on,O
118491,41,treatment,O
118491,41,doses,O
118491,41,of,O
118491,41,bactrim,B-Drug
118491,41,however,O
118491,41,she,O
118491,41,continued,O
118491,41,to,O
118491,41,worsen,O
118491,41,.,O
118491,42,Diagnostic,O
118491,42,bronchoscopy,O
118491,42,was,O
118491,42,considered,O
118491,42,upon,O
118491,42,transfer,O
118491,42,to,O
118491,42,the,O
118491,42,ICU,O
118491,42,however,O
118491,42,the,O
118491,42,patient,O
118491,42,was,O
118491,42,too,O
118491,42,unstable,O
118491,42,for,O
118491,42,the,O
118491,42,procedure,O
118491,42,.,O
118491,42,Flagyl,B-Drug
118491,42,also,O
118491,42,emperically,O
118491,42,started,O
118491,42,for,O
118491,42,C.,B-Reason
118491,42,diff,I-Reason
118491,42,.,O
118491,42,.,O
118491,42,#,O
118491,42,Coagulopathy,B-Reason
118491,42,:,O
118491,42,[,O
118491,42,*,O
118491,42,*,O
118491,42,1-15,O
118491,42,*,O
118491,42,*,O
118491,42,],O
118491,42,liver,O
118491,42,disease,O
118491,42,.,O
118491,42,Pt,O
118491,42,has,O
118491,42,had,O
118491,42,multiple,O
118491,42,red,B-Drug
118491,42,blood,I-Drug
118491,42,cell,I-Drug
118491,42,transfusions,O
118491,42,",",O
118491,42,FFP,B-Drug
118491,42,",",O
118491,42,cryo,B-Drug
118491,42,",",O
118491,42,and,O
118491,42,platelets,B-Drug
118491,42,during,O
118491,42,admission,O
118491,42,.,O
118491,42,Also,O
118491,42,received,O
118491,42,ddAVP,B-Drug
118491,42,for,O
118491,42,uremic,B-Reason
118491,42,platelets,I-Reason
118491,42,.,O
118491,42,She,O
118491,42,had,O
118491,42,an,O
118491,42,episode,O
118491,42,of,O
118491,42,profuse,B-Reason
118491,42,epistaxis,I-Reason
118491,42,in,O
118491,42,the,O
118491,42,setting,O
118491,42,of,O
118491,42,trauma,O
118491,42,from,O
118491,42,Doboff,O
118491,42,feeding,O
118491,42,tube,O
118491,42,that,O
118491,42,could,O
118491,42,only,O
118491,42,be,O
118491,42,controlled,O
118491,42,with,O
118491,42,packing,O
118491,42,",",O
118491,42,Afrin,B-Drug
118491,42,and,O
118491,42,pressure,O
118491,42,by,O
118491,42,ENT,O
118491,42,.,O
118491,43,She,O
118491,43,also,O
118491,43,bled,O
118491,43,from,O
118491,43,her,O
118491,43,paracentesis,O
118491,43,site,O
118491,43,",",O
118491,43,requiring,O
118491,43,transfusion,O
118491,43,and,O
118491,43,sutures,O
118491,43,.,O
118491,43,She,O
118491,43,developed,O
118491,43,DIC,O
118491,43,and,O
118491,43,diffuse,O
118491,43,mucosal,O
118491,43,bleeding,O
118491,43,after,O
118491,43,becoming,O
118491,43,septic,O
118491,43,.,O
118491,43,.,O
118491,43,#,O
118491,43,Auto-Immune,B-ADE
118491,43,Hemolytic,I-ADE
118491,43,Anemia,I-ADE
118491,43,:,O
118491,43,Diagnosed,O
118491,43,with,O
118491,43,auto-immune,O
118491,43,hemolytic,O
118491,43,anemia,O
118491,43,at,O
118491,43,outside,O
118491,43,hospital,O
118491,43,",",O
118491,43,felt,O
118491,43,to,O
118491,43,be,O
118491,43,secondary,O
118491,43,to,O
118491,43,lasix,B-Drug
118491,43,.,O
118491,43,Re-consulted,O
118491,43,hematology,O
118491,43,here,O
118491,43,who,O
118491,43,agreed,O
118491,43,with,O
118491,43,this,O
118491,43,diagnosis,O
118491,43,.,O
118491,43,Lasix,B-Drug
118491,43,was,O
118491,43,held,O
118491,43,during,O
118491,43,admission,O
118491,43,and,O
118491,43,repeat,O
118491,43,coombs,O
118491,43,antibody,O
118491,43,negative,O
118491,43,.,O
118491,43,Reticulocyte,O
118491,43,count,O
118491,43,high,O
118491,43,on,O
118491,43,admission,O
118491,43,(,O
118491,43,29,O
118491,43,%,O
118491,43,),O
118491,43,",",O
118491,43,with,O
118491,43,elevated,O
118491,43,LDH,O
118491,43,",",O
118491,43,tbili,O
118491,43,",",O
118491,43,and,O
118491,43,decreasing,O
118491,43,hematocrit,O
118491,43,suggestive,O
118491,43,of,O
118491,43,ongoing,O
118491,43,hemolysis,O
118491,43,.,O
118491,44,However,O
118491,44,",",O
118491,44,hemolysis,O
118491,44,indices,O
118491,44,improved,O
118491,44,on,O
118491,44,prednisone,B-Drug
118491,44,",",O
118491,44,and,O
118491,44,slow,O
118491,44,prednisone,B-Drug
118491,44,taper,O
118491,44,initiated,O
118491,44,as,O
118491,44,indices,O
118491,44,stabilized,O
118491,44,.,O
118491,44,Blood,O
118491,44,counts,O
118491,44,supported,O
118491,44,as,O
118491,44,needed,O
118491,44,with,O
118491,44,blood,O
118491,44,transfusions,O
118491,44,(,O
118491,44,for,O
118491,44,hgb,O
118491,44,<,O
118491,44,7,O
118491,44,given,O
118491,44,difficult,O
118491,44,crossmatch,O
118491,44,(,O
118491,44,she,O
118491,44,has,O
118491,44,two,O
118491,44,antibodies,O
118491,44,),O
118491,44,.,O
118491,44,.,O
118491,44,#,O
118491,44,GI,O
118491,44,:,O
118491,44,EGD,O
118491,44,performed,O
118491,44,on,O
118491,44,this,O
118491,44,admission,O
118491,44,demonstrated,O
118491,44,grade,O
118491,44,1,O
118491,44,esophageal,O
118491,44,varices,O
118491,44,",",O
118491,44,a,O
118491,44,trans-endoscopic,O
118491,44,NJ,O
118491,44,feeding,O
118491,44,tube,O
118491,44,",",O
118491,44,and,O
118491,44,otherwise,O
118491,44,normal,O
118491,44,EGD,O
118491,44,to,O
118491,44,second,O
118491,44,part,O
118491,44,of,O
118491,44,the,O
118491,44,duodenum,O
118491,44,.,O
118491,44,.,O
118491,44,Medications,O
118491,44,on,O
118491,44,Admission,O
118491,44,:,O
118491,44,folic,B-Drug
118491,44,acid,I-Drug
118491,44,1,O
118491,44,mg,O
118491,44,Qday,O
118491,44,MVI,B-Drug
118491,44,with,I-Drug
118491,44,minerals,I-Drug
118491,44,thiamine,B-Drug
118491,44,100,O
118491,44,mg,O
118491,44,Qday,O
118491,44,prednisone,B-Drug
118491,44,45,O
118491,44,mg,O
118491,44,Qday,O
118491,44,spironolactone,B-Drug
118491,44,50,O
118491,44,mg,O
118491,44,Qday,O
118491,44,lactulose,B-Drug
118491,44,30,O
118491,44,ml,O
118491,45,[,O
118491,45,*,O
118491,45,*,O
118491,45,Hospital1,O
118491,45,*,O
118491,45,*,O
118491,45,],O
118491,45,Mg,B-Drug
118491,45,oxide,I-Drug
118491,45,400,O
118491,45,[,O
118491,45,*,O
118491,45,*,O
118491,45,Hospital1,O
118491,45,*,O
118491,45,*,O
118491,45,],O
118491,45,levoflox,B-Drug
118491,45,500,O
118491,45,mg,O
118491,45,IV,O
118491,45,Qday,O
118491,45,(,O
118491,45,day,O
118491,45,1,O
118491,45,:,O
118491,45,[,O
118491,45,*,O
118491,45,*,O
118491,45,5-23,O
118491,45,*,O
118491,45,*,O
118491,45,],O
118491,45,),O
118491,45,vancomycin,B-Drug
118491,45,750,O
118491,45,mg,O
118491,45,IV,O
118491,45,Qday,O
118491,45,(,O
118491,45,day,O
118491,45,1,O
118491,45,:,O
118491,45,[,O
118491,45,*,O
118491,45,*,O
118491,45,5-23,O
118491,45,*,O
118491,45,*,O
118491,45,],O
118491,45,),O
118491,45,ceftaz,B-Drug
118491,45,2g,O
118491,45,Q8H,O
118491,45,(,O
118491,45,day,O
118491,45,1,O
118491,45,:,O
118491,45,[,O
118491,45,*,O
118491,45,*,O
118491,45,5-23,O
118491,45,*,O
118491,45,*,O
118491,45,],O
118491,45,),O
118491,45,zofran,B-Drug
118491,45,4,O
118491,45,mg,O
118491,45,PO,O
118491,45,prn,O
118491,45,Discharge,O
118491,45,Medications,O
118491,45,:,O
118491,45,none,O
118491,45,Discharge,O
118491,45,Disposition,O
118491,45,:,O
118491,45,Expired,O
118491,45,Discharge,O
118491,45,Diagnosis,O
118491,45,:,O
118491,45,Primary,O
118491,45,Diagnoses,O
118491,45,:,O
118491,45,1,O
118491,45,.,O
118491,46,Alcoholic,O
118491,46,Cirrhosis,O
118491,46,2,O
118491,46,.,O
118491,46,Hepatic,O
118491,46,Encephalopathy,O
118491,46,3,O
118491,46,.,O
118491,46,Nutritional,O
118491,46,Deficiency,O
118491,46,Secondary,O
118491,46,Diagnoses,O
118491,46,:,O
118491,46,Discharge,O
118491,46,Condition,O
118491,46,:,O
118491,46,Expired,O
118491,46,Discharge,O
118491,46,Instructions,O
118491,46,:,O
118491,46,Expired,O
118491,46,Followup,O
118491,46,Instructions,O
118491,46,:,O
118491,46,none,O
